$JNJ Recent Headlines Feds, pharma rivals team up on

New Post Public Reply Private Reply Replies (0) Message Board

Feb 7, 2014 at 10:11 AM

$JNJ Recent Headlines

Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson sees 2014 EPS of $5.75 to $5.85 7:51 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS excluding items $1.24 7:50 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 sales up 4.5% to $18.4B 7:49 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS $1.23 vs. 91 cents 7:48 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Verizon, Delta, IBM are stocks to watch Tuesday 6:28 a.m. Jan. 21, 2014 - Sue Chang
‘Sloppy’ market turns to consumer, tech earnings 8:00 a.m. Jan. 19, 2014 - Wallace Witkowski
Carlyle buying J&J diagnostics unit for $4.15 bln 8:17 a.m. Jan. 16, 2014 - William L. Watts
Carlyle offers $4.15 bln for J&J diagnostics unit 8:04 a.m. Jan. 16, 2014 - William L. Watts
Pharmacyclics shares soar after panel says cancer drug met goals 12:09 p.m. Jan. 7, 2014 - blogs.marketwatch.com

Carlyle to Buy Illinois Tool Unit for $3.2 Billion 7:07 p.m. Feb. 6, 2014 - WSJ.com
Johnson & Johnson (JNJ): Today's Featured Drugs Winner 5:00 p.m. Feb. 6, 2014 - TheStreet.com
Interesting JNJ Put And Call Options For March 14th 11:01 a.m. Feb. 6, 2014 - TheStreet.com
February High Yield Dividend Champion 5:34 a.m. Feb. 6, 2014 - Seeking Alpha
DXCM: Improving the Quality of Life for Children With Diabetes 8:38 p.m. Feb. 5, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Pullback In Stock Prices Makes These Dividend Payers Attractive Again 6:51 p.m. Feb. 5, 2014 - Seeking Alpha
Stocks Tend to Outperform Bonds but with Greater Risk 5:08 p.m. Feb. 5, 2014 - GuruFocus.com
Smith & Nephew Becomes Pharma Family Factor 6:30 a.m. Feb. 5, 2014 - TheStreet.com
AstraZeneca's Prescription for Growth 6:00 a.m. Feb. 5, 2014 - TheStreet.com
Gilead Beats Q4 Estimates, But Ducks Sovaldi Guidance 5:51 p.m. Feb. 4, 2014 - Investors Business Daily
My First Equity Investment Since 2012 9:57 a.m. Feb. 4, 2014 - GuruFocus.com
Is Anyone Really Surprised By The Recent Stock Market Sell-Off?! 9:12 a.m. Feb. 4, 2014 - Seeking Alpha
Merrill Lynch’s Top Dividend and Yield Stocks to Buy During the Pullback 8:36 a.m. Feb. 4, 2014 - 247WallSt.com
Big Pharma firms, NIH to join up to study major diseases 8:28 a.m. Feb. 4, 2014 - Seeking Alpha
Today's Market: What We Are Buying And Looking To Buy On This Pullback 8:13 a.m. Feb. 4, 2014 - Seeking Alpha
Merck's Future Looks Healthier 6:00 a.m. Feb. 4, 2014 - TheStreet.com
2 Steps To A Solid And Profitable Portfolio 5:34 a.m. Feb. 4, 2014 - Seeking Alpha
Rival Companies, NIH Form Pact in Search for New Drugs 11:04 p.m. Feb. 3, 2014 - WSJ.com
Why I Am Buying Philip Morris International 8:16 a.m. Feb. 3, 2014 - GuruFocus.com

United Kingdom Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 1:10 p.m. Feb. 5, 2014 - PR Newswire - PRF
Sustainable Brands® Community Continues to Lead With Brand Innovation Conference 9:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Girard Gibbs LLP Represents Children Allegedly Injured by Risperdal 7:40 p.m. Feb. 4, 2014 - BusinessWire - BZX
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting 10:38 a.m. Feb. 3, 2014 - ACCESSWIRE
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India 9:58 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call for Nominations 9:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 12:01 a.m. Jan. 30, 2014 - PR Newswire - PRF
Risperdal Lawsuit News: Johnson & Johnson Wins Appeal of $257 Million Louisiana Risperdal Verdict, Bernstein Liebhard LLP Reports 11:21 a.m. Jan. 29, 2014 - PR Newswire - PRF
PowerVision Closes $20MM in Its Series D Financing 4:15 p.m. Jan. 28, 2014 - PR Newswire - PRF
Two-Year Data from INNOVATION Trial on INCRAFT® AAA Stent Graft System Continues to Demonstrate Safety and Performance in Treatment of Abdominal Aortic Aneurysms 9:00 a.m. Jan. 28, 2014 - BusinessWire - BZX
Acclarent Launches a Complete Balloon Sinuplasty System for Children who Suffer From Chronic Sinusitis 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
DePuy ASR Lawsuit News: DePuy ASR Hip Recall Continues to Impact Johnson & Johnson Earnings, Bernstein Liebhard LLP Reports 11:28 a.m. Jan. 22, 2014 - PR Newswire - PRF
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
Janssen Announces New Group Targeting Unmet Global Health Needs 8:15 a.m. Jan. 22, 2014 - PR Newswire - PRF
Three-Year Clinical Outcomes from STROLL Trial Demonstrate Sustained Durability and Performance of S.M.A.R.T.® Stent for Treatment of Peripheral Artery Disease 5:56 p.m. Jan. 21, 2014 - BusinessWire - BZX
MD Anderson Announces Collaboration With Johnson & Johnson Innovation On Cancer Immunotherapy 12:38 p.m. Jan. 21, 2014 - PR Newswire - PRF
Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results: 7:45 a.m. Jan. 21, 2014 - PR Newswire - PRF
Fitch: JNJ's Diagnostics Divestiture Makes Strategic Sense 8:47 a.m. Jan. 17, 2014 - BusinessWire - BZX
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics 7:45 a.m. Jan. 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

QuickFi Nabs Top Finovate Award for Fourth Time

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Streamlined AI Video Analytics for Public Safety Unveiled

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Sustainability Investments: $17 Trillion Wager Faces Divergence

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...